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abstract
If ageing is perceived as a disease, then there is the potential that we can cure it! But curing ageing entails understanding it. So 
far, understanding ageing has remained a challenge. However, observations and research, on model organisms and humans 
alike, are evolving fast. In this review, we will start with a discussion of both the damage and the programmed theories of 
ageing. Ultimately, we will focus on calorie restriction and telomere shortening and how these relate to lifespan extension.
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IntroductIon
Someone once said that life should be lived in reverse; die first to get 
it out of the way, work for forty years until you are young enough to 
enjoy your retirement, go to school, play, become a little baby, then 
spend your last nine months floating in the womb. What if, however, 
instead of living life backwards, we could just slow down ageing and 
live longer, healthier lives? What if ageing is just a disease that we 
could cure? So as to answer these questions, we must first attempt to 
understand the process of ageing, specifically, how and why we age.
theorIes of ageIng
In modern gerontology, theories of ageing fall into two main 
categories: damage (or error) and programmed theories.1
damage (or error) theorIes of ageIng
In 1882, the German biologist Dr August Weismann first 
introduced the wear and tear theory of ageing. In essence, his 
theory states that like components of a car, cells and tissues wear 
out from repeated use, first killing themselves and then the entire 
organism. 26 years later, in 1908, Max Rubner postulated the rate of 
living theory, which states that the faster an organism’s metabolism, 
the shorter its lifespan. Rubner created this hypothesis on observing 
that larger animals with slower metabolisms outlived smaller ones. 
In 1928, Raymond Pearl carried out a series of experiments in 
cantaloupe seeds and the common fruit fly Drosophila melanogaster 
further expanding Rubner’s initial observation, i.e. that a slow 
metabolism increases lifespan. 14 years later, in 1942, Johan 
Bjorksten proposed the cross-linking theory of ageing, which states 
that an accumulation of cross-linked proteins damages cells and 
tissues, slowing down biological processes resulting in ageing.2
In 1956, the free radicals theory was developed by Dr Harman,3 
where he proposed that free radicals (e.g. superoxide) damage the 
macromolecular components of the cell; macromolecules (e.g. lipids, 
nucleic acids, proteins, and sugars) are susceptible to free radical 
attack. Studies show that reactive oxygen species (ROS) signalling is 
perhaps the most significant enzyme/gene pathway responsible for cell 
senescence and organismal ageing. Indeed, ROS signalling is considered 
as further development of the free radical theory of ageing.4 Finally, the 
somatic DNA damage theory states that DNA damage accumulates 
with increasing age, causing cells to deteriorate and malfunction. In 
general, most of the damage is repaired over time, however some 
accumulates, primarily because the repair mechanisms (e.g. DNA 
polymerases) do not correct defects as rapidly as they are produced.
Programmed theorIes of ageIng
Three theories fall within this classification. In the programmed 
longevity theory, ageing is the result of genes switching on and off, with 
senescence defined as the time when age-associated diseases such as 
cancer are manifested. In fact, the postulate is that genetic instability is 
the causing factor of both ageing and cancer. It is therefore legitimate 
to ask the question whether long-lived individuals actually have a 
more stable genetic material. Such individuals cannot avoid ageing, but 
ageing could be postponed due to the stable character of their genome, 
which is less susceptible to mutations.5
In the endocrine theory, biological clocks act through hormones 
so as to control the rate of ageing. Studies have confirmed that 
ageing is regulated through hormones, and that the evolutionarily 
conserved insulin/IGF-1 signalling pathway plays an important part 
in the hormonal regulation of ageing.6 Finally, in the immunological 
theory, the immune system is programmed to weaken with time, 
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which leads to an increased susceptibility to infectious disease and 
dysregulated immune responses causing ageing and ultimately 
death. Indeed, a dysregulated immune response has been indirectly 
implicated in Alzheimer’s disease7 and cancer,8 amongst others.
calorIe restrIctIon and Its ImPlIcatIons
Since the 1930s, it has been found that caloric restriction (CR) without 
malnutrition increases lifespan and delays the onset of age-associated 
diseases in species ranging from yeast to worms to mice to monkeys. 
For example, at the University of Wisconsin, a few years ago, Colman 
et al.9,10 subjected a group of rhesus monkeys of about the same age to 
CR. CR monkeys ate 30% fewer calories than they ate prior to the start 
of the study. Over time, it was clear that the monkeys on CR looked 
younger than those on a normal diet at the same age. Colman et al. 
also found that the monkeys on the normal diet had 4x greater risk 
of developing age-associated diseases than those subjected to CR. In 
addition, brain scans of the CR monkeys, when compared to their well-
fed counterparts, showed significantly less atrophy (or cell loss) along 
the surface of the brain, giving applied insight into Alzheimer’s disease. 
Specifically, this is because the human brain shrinks with normal 
ageing, but its shrinking doubles in people with Alzheimer’s.
It has been discovered that down-regulation of the Ras, Sch9 and 
Tor pathways mediate part of the effects of CR.11 Similarly, nutrient 
sensors termed sirtuins are known to mimic the effects of CR. STACs, 
or sirtuin-activating compounds, can in theory extend lifespan. In 
fact, resveratrol and other STACs were found to activate sirtuins 
and increase lifespan in Caenorhabditis elegans and Drosophila 
melanogaster,12 however their effect on human ageing remains unclear.
Perhaps the best example of CR in humans is that of the 
Okinawa population. Situated at the southern tip of Japan in the 
Pacific Ocean, the indigenous Okinawa islanders live for about 
110 years on a CR diet. The Okinawa diet is 20% lower in calories 
than that of an average Japanese. It is rich in anti-oxidants, seafood 
and vegetables, and it is low in fat and sugar.13 Okinawans are also 
active on a daily basis through their traditional practice of martial 
arts, which also contributes to reduced stress.
telomere shortenIng and Its ImPlIcatIons
Like aglets on shoelaces, telomeres keep chromosome ends from 
fraying and sticking to each other. In doing so, the genetic material is 
held intact. It is well-known that each time a cell divides, telomeres 
shorten. If telomeres get too short and cells are no longer able to divide, 
senescence occurs. It is this shortening process that is associated with 
ageing, cancer, and a higher risk of death. Case in point, geneticist 
Richard Cawthon at the University of Utah established that shorter 
telomeres are linked to shorter lives.14 In his study, Cawthon divided 
people into two groups based on telomere length. Overall, he found 
that people with longer telomeres live an average of five years more than 
those with shorter telomeres. Cawthon also showed that people with 
shorter telomeres are 8x more liable to die from infectious disease and 
3x more likely to die from heart disease.
Of note is the disorder known as dyskeratosis congenita 
where telomeres get short much faster than normal. Some of the 
manifestations resemble premature ageing (similar to progeria), 
such as cirrhosis of the liver, a higher risk of infections, intestinal 
disorders, leukaemia and other blood cancers, and pulmonary fibrosis. 
In addition, patients are more prone to endure balding, grey hair, and 
softening of the bones. However, the main consequence of the disorder 
is progressive bone marrow failure, causing early mortality.15 With all 
this, one is lead to presume that restoring telomere length could treat 
ageing and/or age-associated disorders. Professor Elizabeth Blackburn, 
who was awarded the Nobel Prize in Physiology or Medicine in 2009, 
co-discovered telomerase, an enzyme that halts telomere shortening 
and can even lengthen them.16,17 For this reason, after its discovery, 
telomerase was reputed to be the new fountain of youth, as evidenced 
in Jaskelioff et al.’s experiment.18 Jaskelioff et al. showed that mice that 
are engineered to lack telomerase become prematurely old, whereas 
when the enzyme is replenished, the mice’s health is restored.
Similarly, scientists have exploited telomerase in the lab to keep 
human cells dividing beyond their normal, or Hayflick, limit without 
allowing them to become cancerous. In general, the implications for 
this are wide. If telomerase were to be used to “immortalise” human 
cells, we would then be able to mass-produce cells for transplantation, 
including cartilage cells for curing arthritis, insulin-generating cells for 
diabetes, muscle cells for muscular dystrophy, and skin cells for treating 
burns and wounds. In addition, having a limitless source of human cells 
could also help with efforts to test new drugs and gene therapies.
conclusIon
Overall, understanding the causal processes that deteriorate with age is 
critical if we are to meet the growing healthcare requirements of ageing 
human populations. However, this is not a straightforward task; ethical 
and societal implications of ageing research should also be taken into 
consideration. For example, how would treating human ageing affect 
society? What should the ultimate goals of ageing research be? 
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